Atypical teratoid/rhabdoid tumoroids reveal subgroup-specific drug vulnerabilities. Paassen I, Williams J, Rios Arceo C, Ringnalda F, et al. Oncogene 2023;42:1661-1671.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Paassen I, Williams J, Rios Arceo C, Ringnalda F, et al. Atypical teratoid/rhabdoid tumoroids reveal subgroup-specific drug vulnerabilities. Oncogene 2023;42:1661-1671.
PMID: 37020038